A Method to Convert MRI Images of Temperature Change into Images of Absolute Temperature in Solid Tumours
Overview
Pharmacology
Authors
Affiliations
Purpose: During hyperthermia (HT), the therapeutic response of tumours varies substantially within the target temperature range (39-43 °C). Current thermometry methods are either invasive or measure only temperature change, which limits the ability to study tissue responses to HT. This study combines manganese-containing low temperature sensitive liposomes (Mn-LTSL) with proton resonance frequency shift (PRFS) thermometry to measure absolute temperature in tumours with high spatial and temporal resolution using MRI.
Methods: Liposomes were loaded with 300 mM MnSO(4). The phase transition temperature (T(m)) of Mn-LTSL samples was measured by differential scanning calorimetry (DSC). The release of manganese from Mn-LTSL in saline was characterised with inductively coupled plasma atomic emission spectroscopy. A 2T GE small animal scanner was used to acquire dynamic T1-weighted images and temperature change images of Mn-LTSL in saline phantoms and fibrosarcoma-bearing Fisher-344 rats receiving hyperthermia after Mn-LTSL injection.
Results: The T(m) of Mn-LTSL in rat blood was 42.9 ± 0.2 °C (DSC). For Mn-LTSL samples (0.06 mM-0.5 mM Mn(2+) in saline) heated monotonically from 30 °C to 50 °C, a peak in the rate of MRI signal enhancement occurred at 43.1° ± 0.3 °C. The same peak in signal enhancement rate was observed during heating of fibrosarcoma tumours (N = 3) after injection of Mn-LTSL, and the peak was used to convert temperature change images into absolute temperature. Accuracies of calibrated temperature measurements were in the range 0.9-1.8 °C.
Conclusion: The release of Mn(2+) from Mn-LTSL affects the rate of MR signal enhancement which enables conversion of MRI-based temperature change images to absolute temperature.
Advanced Radio Frequency Applicators for Thermal Magnetic Resonance Theranostics of Brain Tumors.
Saha N, Kuehne A, Millward J, Eigentler T, Starke L, Waiczies S Cancers (Basel). 2023; 15(8).
PMID: 37190232 PMC: 10137156. DOI: 10.3390/cancers15082303.
Pominova D, Romanishkin I, Grachev P, Borodkin A, Vanetsev A, Orlovskaya E Lasers Med Sci. 2019; 34(7):1421-1431.
PMID: 30762195 DOI: 10.1007/s10103-019-02742-3.
A Spectral Fiedler Field-based Contrast Platform for Imaging of Nanoparticles in Colon Tumor.
Liu C, Kapoor A, VanOsdol J, Ektate K, Kong Z, Ranjan A Sci Rep. 2018; 8(1):11390.
PMID: 30061558 PMC: 6065424. DOI: 10.1038/s41598-018-29675-1.
Ektate K, Kapoor A, Maples D, Tuysuzoglu A, VanOsdol J, Ramasami S Theranostics. 2016; 6(11):1963-74.
PMID: 27570563 PMC: 4997249. DOI: 10.7150/thno.15922.
Ferromagnetic particles as magnetic resonance imaging temperature sensors.
Hankiewicz J, Celinski Z, Stupic K, Anderson N, Camley R Nat Commun. 2016; 7:12415.
PMID: 27503610 PMC: 4980494. DOI: 10.1038/ncomms12415.